LINC01797

Across TCGA pan-cancer cohorts, LINC01797 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of LINC01797’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where LINC01797 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01797 is over-expressed in tumor, although a few such as BLCA and KIRC show the opposite, repressed pattern.

BLCA, KIRC, and UCEC are the cancer types where LINC01797 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01797 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	Male	III,IV	−1.325	<.001	11	view →
KIRC	All	II,III,IV	−0.134	<.001	10	view →
UCEC	All	All	−1.722	<.001	6	view →
COAD	All	II,III,IV	−0.299	<.001	6	view →
KICH	All	All	−0.212	<.001	5	view →
STAD	All	All	−0.475	.003	4	view →
HNSC	All	All	−0.185	.037	4	view →
LUSC	Male	All	−0.177	<.001	3	view →
READ	All	All	−0.702	.013	2	view →
LUAD	Female	II,III,IV	−0.242	.016	2	view →
CHOL	All	All	+0.121	.004	2	view →
KIRP	All	All	−0.084	.003	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

LINC01797–BLCA

Open the BLCA breakdown →